UTHR
United Therapeutics Corporation
NASDAQ · Healthcare · Biotechnology · US
$487.61
−0.54%Margins
Gross margin
86.1%
EBITDA margin
52.4%
EBIT margin
44.5%
Net margin
41.6%
FCF margin
34.6%
20.5%
Return on equity
18.2%
Return on assets
21.9%
Return on invested capital
0.45x
Asset turnover
$1.7B
Cash from operations
$62
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026